Free Trial
→ URGENT: This Altcoin Opportunity Won’t Wait – Act Now (From Crypto Swap Profits) (Ad) Free NVS Stock Alerts

Novartis (NVS) SEC Filings & 10K Form

Novartis logo
$97.11 +0.34 (+0.35%)
(As of 12/20/2024 04:33 PM ET)
Compare

Recent Novartis SEC Filings

Export to Excel
DateFilerForm TypeView
11/25/2024
9:20 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
5:20 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
3:38 PM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/17/2024
4:08 PM		Novartis (Filer)
Novartis Capital CORP (Filer)
Form 424B5
09/17/2024
1:05 PM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
4:12 PM		Novartis (Subject)
Form FWP
09/16/2024
7:44 AM		Novartis (Filer)
Novartis Capital CORP (Filer)
Form 424B5
09/16/2024
7:12 AM		Novartis (Filer)
Novartis Capital CORP (Filer)
Form F-3ASR
08/15/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D/A
08/13/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
08/12/2024
2:30 PM		Kowalski Robert William (Reporting)
Novartis (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
7:12 PM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
08/02/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
08/01/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/31/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/30/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/29/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/25/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/18/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/18/2024
5:09 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/11/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
07/05/2024
5:02 AM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T
06/21/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D/A
06/20/2024
2:38 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-C
06/17/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D/A
06/10/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D/A
06/04/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
05/31/2024
5:00 AM		Novartis (Filer)
Form SD
Specialized Disclosure Report  
05/22/2024
11:42 AM		Gal Aharon (Reporting)
Novartis (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
05/07/2024
3:45 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
05/06/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
05/02/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/25/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/23/2024
5:06 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
3:31 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/18/2024
1:33 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC 13D
04/17/2024
3:30 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/16/2024
4:07 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
04/15/2024
2:44 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T/A
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now
04/11/2024
5:01 AM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-T
02/15/2024
3:15 PM		Novartis (Filer)
Form S-8 POS
02/06/2024
3:52 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-C
02/05/2024
4:06 PM		MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
Form SC TO-C
02/02/2024
1:18 PM		BlackRock Inc. (Filed by)
Novartis (Subject)
Form SC 13G/A
01/31/2024
6:43 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2024
6:43 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2024
6:44 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2024
6:44 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2024
6:38 AM		Novartis (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
01/31/2024
6:42 AM		Novartis (Filer)
Form IRANNOTICE
01/08/2024
5:13 AM		Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:NVS) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners
Amazon coin set to soar 25X – starting December 16th?
This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...
True Market Insiders | Sponsored
Did You See Trump’s Bombshell Exec. Order 001?
Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
The #1 Crypto for AI
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...
Weiss Ratings | Sponsored
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
Elon Musk’s chilling warning for humanity
The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...
The Freeport Society | Sponsored
Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
Crypto 101 Media | Sponsored
Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...
Porter & Company | Sponsored